References
- Miller, C, Mohandas, T, Wolf, D, et al. Human p53 gene localized to short arm of chromosome 17. Nature 1986; 319: 783–784
- Eliyahu, D, Michalovitz, D, Eliyahu, S, et al. Wild-type p53 can inhibit oncogene-mediated focus formation. Proc Natl Acad Sci USA 1989; 86: 8763–8767
- Nigro, JM, Baker, SJ, Preisinger, AC, et al. Mutations in the p53 gene occur in diverse human tumor types. Nature 1989; 342: 705–708
- Porter, PL, Gown, AM, Kramp, SG, et al. Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacam-fixed, embedded tissue. Am J Pathol 1992; 140: 145–153
- Wang, DG, Johnston, CF, Anderson, N, et al. Overexpression of the tumor suppressor gene p53 is not implicated in neuroendocrine tumor carcinogenesis. J Pathol 1995; 175: 397–401
- O'Dowd G, Gosney JR. Absence of overexpression of p53 protein by intestinal carcinoid tumors. J Pathol 1995; 175: 403–404
- Bartek, J, Iggo, R, Gannon, J, et al. Genetic and immunocytochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene 1990; 5: 893–899
- Lane DP, Benchimol S. p53: oncogene or anti-oncogene?. Genes Dev 1990; 4: 1–8
- Lee, CS, Rush, M, Charalambous, D, et al. Immunohistochemical demonstration of the p53 tumor suppressor gene product in cancer of the pancreas and chronic pancreatitis. J Gastroenterol Hepatol 1993; 8: 465–469
- Heitz, PU, Kasper, M, Polak, JM, et al. Pancreatic endocrine tumors: immunocytochemical analysis of 125 tumors. Human Path 1982; 13(3)263–271
- Heitz, PU, von Herbay, G, Kloppel, G, et al. The expression of subunits of human chorionic gonadotrophin (hCG) by nontrophoblastic, nonendocrine, and endocrine tumors. Am J Clin Pathol 1987; 88: 467–472
- Heitz, PU, Kasper, M, Kloppel, G, et al. Glycoprotein-hormone alphachain production by pancreatic endocrine tumors: a specific marked for malignancy. Immunocytochemical analysis of tumors of 155 patients. Cancer 1983; 51: 277–282
- Graeme-Cook F, Nardi G, Compton CC. Immunocytochemical staining for human chorionic gonadotrophin subunits does not predict malignancy in insulinomas. Am J Clin Pathol 1990; 93: 273–276
- Lee, CS, Charlton, I, Williams, R, Dhillon, AP, et al. Malignant potential of aneuploid pancreatic endocrine tumors. J Pathol 1993; 169: 451–456
- Bartek, J, Bartkova, J, Vojtesek, B, et al. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene 1991; 6: 1699–1703
- Hall PA, Lane DP. p53 in tumor pathology: can we trust immunohistochemistry? — Revisited. J Pathol 1994; 172: 1–4